market

Pfizer, Gilead, GSK set to dominate infectious diseases market


3d Rendering of word infection

matdesign24/iStock via Getty Images

Pfizer (NYSE:PFE), Gilead Sciences (GILD), and GSK (GSK) are in position to control a majority of the infectious disease treatment market due to increasing demand for COVID-19 drugs and HIV medications.

That’s the assessment from analytics and consulting firm GlobalData, which

Readers Also Like:  Coca-Cola chief bags £500k 'cost-of-living' handout
Readers Also Like:  Sensex falls 202 pts on losses in IT and bank stocks; Nifty above 19,300; Concord Biotech up 27% in debut



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.